Addition of Transcranial Direct Current Stimulation and Transcutaneous Electrical Nerve Stimulation to an Education and Exercise Program in Subjects With Chronic Pain Due to Knee Osteoarthritis

Chronic Pain Clinical Trial

Official title:

Addition of Transcranial Direct Current Stimulation and Transcutaneous Electrical Nerve Stimulation to an Education and Exercise Program in Subjects With Chronic Pain Due to Knee Osteoarthritis.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05138471
• Other study ID #: JOS-2021-01
• Status: Completed
• Phase: N/A
• Start date: November 17, 2021
• Est. completion date: May 1, 2024

Study information

• Verified date: January 2024
• Source: Universidad de Murcia
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Knee osteoarthritis has a very high prevalence in the population over 50 years of age. Patients with osteoarthritis often suffer from chronic pain that becomes disabling, affecting both quality of life and mental and physical health. This pathology has also been linked to maladaptive plasticity in the brain, which can contribute to chronic pain. Therapies with neuromodulatory approaches, such as transcranial direct current stimulation (tDCS) and peripheral electrical stimulation (TENS), have been used therapeutically to counteract the maladaptive plasticity of the brain.

Transcranial therapy and TENS can be a possible effective treatment in the rehabilitation services of the health system for the improvement of chronic pain and quality of life in different pathologies, such as chronic low back pain, fibromyalgia or knee and hip osteoarthritis.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 65
• Est. completion date: May 1, 2024
• Est. primary completion date: March 1, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 50 Years and older

Eligibility

Inclusion Criteria:

• Adults over fifty years of age with a diagnosis of knee osteoarthritis by radiography.

• Chronic pain of more than six months, compliance with the diagnostic criteria for knee osteoarthritis according to the Osteoarthritis Research Society International (OARSI) guideline:

• Pain in Analog Visual Scale more than 4/10

• Matutinal less than 30 minutes

• Absence of hyperthermia upon palpation in the joint

• Alteration of the bone image

• Crepitus

Exclusion Criteria:

• Patients who can provide low-quality or biased information discriminated by the Mini-Mental State Examination (Score less than 24).

• Severe hearing, visual or sensory impairment or comorbidities that prevent the correct completion of the questionnaires and mobility activities.

• Patients who have undergone knee replacement surgery on the contralateral knee.

• Patients who have received intervention (infiltration, blockages, etc...) in the last 6 weeks.

• Pain due to tendinopathy, knee fracture, low back pain radiating to the knee, or fibromyalgia.

• Patients who decline to participate out of fear or denial of therapy.

• Severe heart disease that prevent exercise.

• Body Mass Index above 45.

• Patients with neuropsychiatric disorders (schizophrenia, epilepsy or bipolar disorders) or taking medication for these conditions (antiepileptic drugs).

• Patients with metallic implants in the area (skull or knee).

Related Conditions & MeSH terms

• Chronic Pain
• Osteo Arthritis Knee
• Osteoarthritis
• Osteoarthritis, Knee

Intervention

Device:
• transcranial direct current stimulation (tDCS)
tDCS intervention will consist in placing two electrodes, the cathode on the supraorbital surface on the same side as the painful knee, and the anode on the parietal area, corresponding to the area of the primary motor cortex, on the opposite side. The intensity will be 2 milli amperes (mA) and stimulation will be 20 minutes. The placebo will generate an initial sensation, and then descend until the stimulation is turned off.
• TENS
TENS intervention will consist in placing two electrodes on the sides of the patella of the affected knee. The frequency will be 10Herzts and the intensity will remain at a sensitive threshold level, without reaching the motor. The placebo will generate a sensation of current to descend to the minimum value that the equipment allows. Stimulation will last for 20 minutes.

Behavioral:
• Exercise and General Education
The General Education Intervention consisting in an educational program will be applied to all groups using audiovisual material to increase the subject's knowledge about his/her pathology, about chronic pain and recommendations for supervised exercise based on the NEMEX protocol for osteoarthritis (Ageberg et al.)18: the participants will be taught analytical strengthening exercises (quadriceps and hamstrings) and neuromuscular functional exercises (getting up from the chair or going up a step), with their detailed dosage (2 to 3 series with 10 to 15 repetitions) and a home follow-up model where the participant must record compliance with exercise as well as pain during activity.

Locations

Country	Name	City	State
Spain	University of Murcia	Murcia

Sponsors (1)

Lead Sponsor	Collaborator
Universidad de Murcia

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Chronic Knee Pain	The Visual Analogic Scale will be used to assess the impact on chronic knee pain. The values range from 0 to 10 (0 = No pain, 10 = the worst pain).	Through study completion, an average of 1 year.
Secondary	Function and Quality of Life	The Western Ontario and McMaster (WOMAC) scale will be used to assess pain, function, and quality of life in knee osteoarthritis and range from 0 to 96 (higher score, worst outcome).	Through study completion, an average of 1 year.
Secondary	Force	Using a dynamometer for quadriceps muscle (measurement in Kg, higher score means better outcome).	Through study completion, an average of 1 year.
Secondary	Balance	A short physical performance battery (SPPB) will be used to measure balance. SPPB ranges from 0 (worst) to 12 (best).	Through study completion, an average of 1 year.
Secondary	Gait properties.	6 Minutes Walk Test (meters) measure exercise tolerance, less than 350 meters is high risk of death in some patients. More meters, more score.	Through study completion, an average of 1 year.
Secondary	Coordination and Balance	Timed Up and Go Test (TUG), less than 10 seconds (low risk of falls) more than 20 seconds (high risk of falls).	Through study completion, an average of 1 year.
Secondary	Uncertainly	Mishel's Uncertainly Scale (MUIS) range from 55 to 121 (more score, greater uncertainly, worst outcome).	Through study completion, an average of 1 year.
Secondary	Catastrophizing	The Pain Catastrophizing Scale (PCS) range from 0 to 52 (more score, greater catastrophizing, worst outcome).	Through study completion, an average of 1 year.
Secondary	Kinesiophobia	The Tampa Scale of Kinesiophobia (TSK) range from 11 to 44 (higher values are worst outcome).	Through study completion, an average of 1 year.
Secondary	Central Sensitization	8Central Sensitization Inventory (CSI) range from 0 to 100 (higher values are worst outcome)	Through study completion, an average of 1 year.